66 results
DEFA14A
CTLT
Catalent, Inc.
5 Feb 24
Additional proxy soliciting materials
5:22pm
on our long-term objectives in life sciences innovation.
As discussed last year, the Strategic and Operational Review Committee of our Board had been … in life sciences innovation.
Like Catalent, Novo Holdings is a mission-driven company, and part of its mission is to invest in companies that address
DEFA14A
CTLT
Catalent, Inc.
5 Feb 24
Additional proxy soliciting materials
7:03am
has built a comprehensive end-to-end offering of services and capabilities to drive innovation in the healthcare system and improve patient outcomes … of society and the planet. The Foundation’s mission is to progress research and innovation in the prevention and treatment of cardiometabolic
8-K
EX-99.1
589xusaoc 87
5 Feb 24
Novo Holdings to Acquire Catalent
7:00am
PRER14A
smwhch8k
7 Sep 21
Preliminary revised proxy
4:26pm